Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Northerencentson Mar 30, 2021 12:57am
461 Views
Post# 32904130

The good the bad and the ugly

The good the bad and the ugly

I've held this for years, and fell head over heels for the potential, in all the bears defence this stock has been a wild ride the last few years I've seen it run 300-400% and back numerous times, that being said it has moved like that on minuscule fundamental changes.

   I think a lot of us know how hard and fast this will fly in due time including the bears sometimes you see them work it down in times of a lull and sometimes they sweat like the past week. 

 We are also sitting at near the top of many of those mega market cap swings, unlike previous times it hasn't been able to get clawed down, it's actually consolidated here for the first time in years! 

Aristotle is a mega test and a big deal, the partners and clients we have developed are as well. The massive increase in revenue on a beautiful trajectory, hopefully cash flow positive here soon is big , and yes covid has helped us big time. Instuitions holding the line 

The Catalyst are stacked up here to make a splash, we all know the company has struggled to market and execute in the biopsy space being a small low capital company in a big sea, so the track record is questionable.but I'm willing to give them the benefit of the doubt 

I'd say the odds are in the bulls favour 


 

<< Previous
Bullboard Posts
Next >>